Intervention

bupropion

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions9

Lead sponsors shown5

Clinical trials

6 shown

Electroencephalography (EEG) Signal ProcessingNCT01369290 · 2009-10-01

Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) TreatmentNCT03927950 · 2007-01-01

Dichotic Listening as a Predictor of Medication Response in DepressionNCT00404755 · 2006-07-01

Fluoxetine and Bupropion to Treat Patients With Depression and AlcoholismNCT00449007 · 2006-02-01

Craving, Binge Eating and ObesityNCT00414167 · 2005-12-01

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)NCT00012558 · 1998-09-01

Common conditions

Major Depressive Disorder2 Alcoholism1 Binge Eating Disorder1 Bipolar Disorder1 Depression1 Dysthymia1 Major Depression1 Obesity1 Suicidal Behavior1

Leading sponsors

New York State Psychiatric Institute2 National Institute of Mental Health (NIMH)1 St. Joseph's Healthcare Hamilton1 University of Tartu1 Yale University1

Trial status mix

COMPLETED4

TERMINATED1

UNKNOWN1

Phase mix

PHASE43

NA1

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.